Faster and universal vaccine development with PELS technology for fast antigen discovery.
An antigen is a part of a pathogen that triggers a immune response. Antigen discovery is the first and most difficult part of vaccine development. Finding a common antigen across multiple strains of a pathogen is even more difficult as it requires repeating antigen discovery over and over and over again. PathoVacs can compete in universal vaccine development because of its PELS technology which dramatically truncates antigen discovery.